Carrillo, J.; Calvete, O.; Pintado Berninches, L.; Manguan-García, C.; Sevilla Navarro, J.; Arias-Salgado, E.G.; Sastre, L.; Guenechea, G.; López Granados, E.; de Villartay, J.P.; Revy, P.; Benitez, J.; Perona, R. "Mutations in xlf/nhej1/cernunnos Gene Results In Downregulation of Telomerase Genes Expression and Telomere Shortening.". Hum. Mol. Genet.. (): . (2017). (PMID: 28369633).
Calvete, O.; Martinez, P.; Garcia-Pavia, P.; Benitez-Buelga, C.; Paumard-Hernández, B.; Fernandez, V.; Dominguez, F.; Salas, C.; Romero-Laorden, N.; Garcia-Donas, J.; Carrillo, J.; Perona, R.; Triviño, J.C.; Andrés, R.; Cano, J.M.; Rivera, B.; Alonso-Pulpon, L.; Setien, F.; Esteller, M.; Rodriguez-Perales, S.; Bougeard, G.; Frebourg, T.; Urioste, M.; Blasco, M.A.; Benítez, J. "A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.". Nat Commun. 6(): 8383. (2015). (PMID: 26403419).
Benitez-Buelga, C.; Sanchez-Barroso, L.; Gallardo, M.; Apellániz-Ruiz, M.; Inglada-Pérez, L.; Yanowski, K.; Carrillo, J.; Garcia-Estevez, L.; Calvo, I.; Perona, R.; Urioste, M.; Osorio, A.; Blasco, M.A.; Rodriguez-Antona, C.; Benitez, J. "Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients.". Breast Cancer Res. Treat.. 149(2): 385-394. (2015). (PMID: 25528024).
Manguan-Garcia, C.; Pintado-Berninches, L.; Carrillo, J.; Machado-Pinilla, R.; Sastre, L.; Pérez-Quilis, C.; Esmoris, I.; Gimeno, A.; García-Giménez, J.L.; Pallardó, F.V.; Perona, R. "Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.". PLoS ONE. 9(7): e101424. (2014). (PMID: 24987982).
Carrillo, J.; González, A.; Manguán-García, C.; Pintado-Berninches, L.; Perona, R. "p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.". Clin Transl Oncol. 16(6): 529-538. (2014). (PMID: 24065372).
Machado-Pinilla, R.; Carrillo, J.; Manguan-Garcia, C.; Sastre, L.; Mentzer, A.; Gu, B.W.; Mason, P.J.; Perona, R. "Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.". Clin Transl Oncol. 14(10): 755-763. (2012). (PMID: 22855157).
Carrillo, J.; Martínez, P.; Solera, J.; Moratilla, C.; González, A.; Manguán-García, C.; Aymerich, M.; Canal, L.; Del Campo, M.; Dapena, J.L.; Escoda, L.; García-Sagredo, J.M.; Martín-Sala, S.; Rives, S.; Sevilla, J.; Sastre, L.; Perona, R. "High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.". Blood Cells Mol. Dis.. 49(3-4): 140-146. (2012). (PMID: 22664374).
Perona, R.; Machado-Pinilla, R.; Manguan, C.; Carrillo, J. "Telomerase deficiency and cancer susceptibility syndromes.". Clin Transl Oncol. 11(11): 711-714. (2009). (PMID: 19917533).
Carrillo, J.; Agra, N.; Fernández, N.; Pestaña, A.; Alonso, J. "Devazepide, a nonpeptide antagonist of CCK receptors, induces apoptosis and inhibits Ewing tumor growth.". Anticancer Drugs. 20(7): 527-533. (2009). (PMID: 19407653).
García-Aragoncillo, E.; Carrillo, J.; Lalli, E.; Agra, N.; Gómez-López, G.; Pestaña, A.; Alonso, J. "DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.". Oncogene. 27(46): 6034-6043. (2008). (PMID: 18591936).
Mendiola, M.; Carrillo, J.; García, E.; Lalli, E.; Hernández, T.; de Alava, E.; Tirode, F.; Delattre, O.; García-Miguel, P.; López-Barea, F.; Pestaña, A.; Alonso, J. "The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.". Int J Cancer. 118(6): 1381-1389. (2006). (PMID: 16206264).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info